Ong Kang Wei
Dividend growth investing, growth at reasonable price, long-term horizon

Landauer: A Turnaround Play With Fabulous Dividends, A Great Business And Niche

In recent months, Landauer (NYSE:LDR)'s price has been on a strong downtrend, losing 19% year-to-date, and 25% from its February 2013 peak. This is due mainly to pressured earnings from aggressive acquisitions (IZI Medical, 2011) and numerous internal upgrades (especially in its IT platforms). This have led to investors being uncertain about the future prospects of the company, pushing the company's stock price lower. In this article, I will analyze the company, and investigate why the company may be worth buying as a turnaround play.


Before going in-depth into Landauer's business, here are a few key figures and financials.

Price (27.06.2013) $48.39 Market Cap $456.75M Adjusted Earnings (2012) $19.27M (P/E: 23.4) Sales (Trailing 12-months) $147.80M (P/S: ...
Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details